Current status of molecularly targeted drugs for the treatment of advanced thyroid cancer

被引：5
|
作者：
Takami, Hiroshi E. [1 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, Tokyo 1738605, Japan
来源：
ENDOCRINE JOURNAL | 2011年 / 58卷 / 03期
关键词：
Molecularly targeted drugs; Kinase inhibitors; Differentiated thyroid carcinoma; Medullary thyroid carcinoma; PHASE-II TRIAL; SORAFENIB; CARCINOMA;
D O I：
10.1507/endocrj.K11E-076
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prognosis of almost all thyroid cancers is good, but some patients have indications for these molecularly targeted. drugs. Some of these drugs, i.e., vandetanib, XL-184, sorafenib, motesanib, axitinib, and pazopanib, are clearly useful clinically.
引用
收藏
页码：151 / 153
页数：3
相关论文
共 50 条
  • [1] Treatment of advanced thyroid cancer: role of molecularly targeted therapies
    Covell, Lorinda L.
    Ganti, Apar Kishor
    TARGETED ONCOLOGY, 2015, 10 (03) : 311 - 324
  • [2] Molecularly targeted drugs for the treatment of cancer: oral complications and pathophysiology
    Dietrich, E. M.
    Antoniades, K.
    HIPPOKRATIA, 2012, 16 (03) : 196 - 199
  • [3] Development of molecular targeted drugs for advanced thyroid cancer in Japan
    Takami, Hiroshi
    Ito, Koichi
    Sugino, Kiminori
    ENDOCRINE JOURNAL, 2014, 61 (09) : 833 - 839
  • [4] Advances in the treatment of thyroid cancer in the era of molecularly targeted therapies
    Malouf, G.
    Baudin, E.
    Soria, J. -C.
    Schlumberger, M.
    BULLETIN DU CANCER, 2009, 96 (01) : 95 - 101
  • [5] Targeted therapies for advanced thyroid cancer
    Puxeddu, Efisio
    Romagnoli, Serena
    Dottorini, Massimo Eugenio
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (01) : 13 - 21
  • [6] Targeted therapy in refractory thyroid cancer: current achievements and limitations
    Brilli, Lucia
    Pacini, Furio
    FUTURE ONCOLOGY, 2011, 7 (05) : 657 - 668
  • [7] The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies
    Lirov, Roy
    Worden, Francis P.
    Cohen, Mark S.
    DRUGS, 2017, 77 (07) : 733 - 745
  • [8] Targeted therapies and thyroid cancer: an update
    de la Fouchardiere, Christelle
    Droz, Jean-Pierre
    ANTI-CANCER DRUGS, 2011, 22 (07) : 688 - 699
  • [9] Current status of targeted therapies in advanced gastric cancer
    De Vita, Ferdinando
    Giuliani, Francesco
    Silvestris, Nicola
    Rossetti, Sabrina
    Pizzolorusso, Antonio
    Santabarbara, Giuseppe
    Galizia, Gennaro
    Colucci, Giuseppe
    Ciardiello, Fortunato
    Orditura, Michele
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 : S29 - S34
  • [10] Molecularly Targeted Therapy for Advanced Hepatocellular Carcinoma in 2012: Current Status and Future Perspectives
    Zhu, Andrew X.
    SEMINARS IN ONCOLOGY, 2012, 39 (04) : 493 - 502
12345